Biotech

All Articles

James Wilson leaving behind Penn to release 2 new biotechs

.After much more than three decades, gene treatment pioneer James Wilson M.D., Ph.D., is leaving beh...

3 biotechs make an effort to defeat the summer warmth by shedding staff

.As biotechs attempt to transform a fresh page in August, at the very least 3 providers have dropped...

venBio raises $528M for 5th lifestyle scientific researches VC fund

.Professional financial backing firm venBio has actually lifted an additional half a billion dollars...

Otsuka pays $800M for Jnana and its own clinical-stage PKU medicine

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapies for $800 million so the Oriental bio...

FibroGen lays off 75% of US team as property fails 2 more tests

.FibroGen is actually substantially reorganizing its own service, laying off 75% of its own U.S. sta...

Tracon winds down weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has actually chosen to relax procedures full weeks after an injectable immun...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M reduction on failed epilepsy medication, promotes FDA run

.Our team presently know that Takeda is expecting to locate a pathway to the FDA for epilepsy medica...

VBI Vaccines files for bankruptcy, looks for possession purchase

.Immunology biotech VBI Vaccines is drifting alarmingly near to the defining moment, with plannings ...

Celldex anti-cKIT antitoxin lower hives in an additional phase 2 study

.It is actually not easy to muscle mass in on a space as reasonable as immunology, but Celldex Thera...